{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T13:48:14Z","timestamp":1773236894259,"version":"3.50.1"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2002,11,22]],"date-time":"2002-11-22T00:00:00Z","timestamp":1037923200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2002,11,22]],"date-time":"2002-11-22T00:00:00Z","timestamp":1037923200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Gene Ther"],"published-print":{"date-parts":[[2002,12,1]]},"DOI":"10.1038\/sj.cgt.7700535","type":"journal-article","created":{"date-parts":[[2003,1,9]],"date-time":"2003-01-09T15:34:47Z","timestamp":1042126487000},"page":"961-966","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":115,"title":["RNA viruses as virotherapy agents"],"prefix":"10.1038","volume":"9","author":[{"given":"Stephen J","family":"Russell","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2002,11,22]]},"reference":[{"key":"BF7700535_CR1","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1016\/0959-8049(94)90477-4","volume":"8","author":"SJ Russell","year":"1994","unstructured":"Russell SJ . Replicating vectors for gene therapy of cancer: risks, limitations and prospects Eur J Cancer 1994 8: 1165\u20131171","journal-title":"Eur J Cancer"},{"key":"BF7700535_CR2","first-page":"437","volume":"5","author":"SJ Russell","year":"1994","unstructured":"Russell SJ . Replicating vectors for cancer therapy: a question of strategy Semin Cancer Biol 1994 5: 437\u2013443","journal-title":"Semin Cancer Biol"},{"key":"BF7700535_CR3","doi-asserted-by":"publisher","first-page":"1907","DOI":"10.1002\/1097-0142(197412)34:6<1907::AID-CNCR2820340609>3.0.CO;2-4","volume":"34","author":"T Asada","year":"1974","unstructured":"Asada T . Treatment of human cancer with mumps virus Cancer 1974 34: 1907\u20131928","journal-title":"Cancer"},{"key":"BF7700535_CR4","first-page":"1305","volume-title":"Fields' Virology","author":"R Lamb","year":"2001","unstructured":"Lamb R, Kolakofsky D . Paramyxoviridae: the viruses and their replication In: Knipe D, Howley P, eds Fields' Virology Philadelphia: Lippincott, Williams and Wilkins 2001 1305\u20131340"},{"key":"BF7700535_CR5","first-page":"487","volume":"12","author":"Y Shimizu","year":"1988","unstructured":"Shimizu Y, Hasumi K, Okudaira Y et al. Immunotherapy of advanced gynecologic cancer: patients utilizing mumps virus Cancer Detect Prev 1988 12: 487\u2013495","journal-title":"Cancer Detect Prev"},{"key":"BF7700535_CR6","first-page":"452","volume-title":"Disease of Poultry","author":"CW Beard","year":"1984","unstructured":"Beard CW, Hanson RP . Newcastle disease In: Hofstad MS, ed Disease of Poultry 8th ed Ames: Iowa State University Press 1984 452\u2013470"},{"key":"BF7700535_CR7","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1016\/0022-4804(92)90310-V","volume":"52","author":"KW Reichard","year":"1992","unstructured":"Reichard KW, Lorence RM, Cascino CJ et al. Newcastle disease virus selectively kills human tumor cells J Surg Res 1992 52: 448\u2013453","journal-title":"J Surg Res"},{"key":"BF7700535_CR8","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/S0304-3835(01)00617-6","volume":"172","author":"A Phuangsab","year":"2001","unstructured":"Phuangsab A, Lorence RM, Reichard KW et al. Newcastle disease virus therapy of human tumor xenografts: antitumor effects of local or systemic administration Cancer Lett 2001 172: 27\u201336","journal-title":"Cancer Lett"},{"key":"BF7700535_CR9","first-page":"6017","volume":"54","author":"RM Lorence","year":"1994","unstructured":"Lorence RM, Katubig BB, Reichard KW et al. Complete regression of human fibrosarcoma xenografts after local Newcastle disease virus therapy Cancer Res 1994 54: 6017\u20136021","journal-title":"Cancer Res"},{"key":"BF7700535_CR10","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.1093\/jnci\/86.16.1228","volume":"86","author":"RM Lorence","year":"1994","unstructured":"Lorence RM, Reichard KW, Katubig BB et al. Complete regression of human neuroblastoma xenografts in athymic mice after local Newcastle disease virus therapy J Natl Cancer Inst 1994 86: 1228\u20131233","journal-title":"J Natl Cancer Inst"},{"key":"BF7700535_CR11","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1002\/(SICI)1099-1654(199904\/06)9:2<83::AID-RMV244>3.0.CO;2-5","volume":"9","author":"Y Nagai","year":"1999","unstructured":"Nagai Y . Paramyxovirus replication and pathogenesis. Reverse genetics transforms understanding Rev Med Virol 1999 9: 83\u201399","journal-title":"Rev Med Virol"},{"key":"BF7700535_CR12","doi-asserted-by":"publisher","first-page":"2251","DOI":"10.1200\/JCO.2002.08.042","volume":"20","author":"AL Pecora","year":"2002","unstructured":"Pecora AL, Rizvi N, Cohen GI et al. Phase I trial of intravenous administration of PV701, an oncolytic virus, in patients with advanced solid cancers J Clin Oncol 2002 20: 2251\u20132266","journal-title":"J Clin Oncol"},{"key":"BF7700535_CR13","first-page":"1401","volume-title":"Fields' Virology","author":"D Griffin","year":"2001","unstructured":"Griffin D . Measles virus In: Knipe DM, Howley PM, eds Fields' Virology 4th edition Philadelphia: Lippincott, Williams and Wilkins 2001 Vol. 1: 1401\u20131441"},{"key":"BF7700535_CR14","doi-asserted-by":"crossref","unstructured":"Bluming AZ, Ziegler JL . Regression of Burkitt's lymphoma in association with measles infection Lancet 1971 105\u2013106","DOI":"10.1016\/S0140-6736(71)92086-1"},{"key":"BF7700535_CR15","doi-asserted-by":"publisher","first-page":"3746","DOI":"10.1182\/blood.V97.12.3746","volume":"97","author":"D Grote","year":"2001","unstructured":"Grote D, Russell SJ, Cornu TI et al. Live attenuated measles virus induces regression of human lymphoma xenografts in immunodeficient mice Blood 2001 97: 3746\u20133754","journal-title":"Blood"},{"key":"BF7700535_CR16","first-page":"4656","volume":"62","author":"K-W Peng","year":"2002","unstructured":"Peng K-W, TenEyck C, Galanis E et al. Intraperitoneal therapy of ovarian cancer using an engineered measles virus Cancer Res 2002 62: 4656\u20134662","journal-title":"Cancer Res"},{"key":"BF7700535_CR17","doi-asserted-by":"publisher","first-page":"2002","DOI":"10.1182\/blood.V98.7.2002","volume":"98","author":"KW Peng","year":"2001","unstructured":"Peng KW, Ahmann GJ, Pham L et al. Systemic therapy of myeloma xenografts by an attenuated measles virus Blood 2001 98: 2002\u20132007","journal-title":"Blood"},{"key":"BF7700535_CR18","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1038\/nm0502-527","volume":"8","author":"KW Peng","year":"2002","unstructured":"Peng KW, Facteau S, Wegman T et al. Non-invasive in vivo monitoring of trackable viruses expressing soluble marker peptides Nat Med 2002 8: 527\u2013531","journal-title":"Nat Med"},{"key":"BF7700535_CR19","doi-asserted-by":"publisher","first-page":"4399","DOI":"10.1128\/JVI.75.9.4399-4401.2001","volume":"75","author":"N Ono","year":"2001","unstructured":"Ono N, Tatsuo H, Hidaka Y et al. Measles viruses on throat swabs from measles patients use signaling lymphocytic activation molecule (CDw150) but not CD46 as a cellular receptor J Virol 2001 75: 4399\u20134401","journal-title":"J Virol"},{"key":"BF7700535_CR20","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1016\/S0161-5890(99)00115-7","volume":"36","author":"K Jurianz","year":"1999","unstructured":"Jurianz K, Ziegler S, Garcia-Schuler H et al. Complement resistance of tumor cells: basal and induced mechanisms Mol Immunol 1999 36: 929\u2013939","journal-title":"Mol Immunol"},{"key":"BF7700535_CR21","doi-asserted-by":"publisher","first-page":"1431","DOI":"10.1099\/0022-1317-83-6-1431","volume":"83","author":"C Erlenhofer","year":"2002","unstructured":"Erlenhofer C, Duprex WP, Rima BK et al. Analysis of receptor (CD46, CD150) usage by measles virus J Gen Virol 2002 83: 1431\u20131436","journal-title":"J Gen Virol"},{"key":"BF7700535_CR22","doi-asserted-by":"crossref","first-page":"3955","DOI":"10.1128\/jvi.69.6.3955-3958.1995","volume":"69","author":"LM Esolen","year":"1995","unstructured":"Esolen LM, Park SW, Hardwick JM et al. Apoptosis as a cause of death in measles virus\u2013infected cells J Virol 1995 69: 3955\u20133958","journal-title":"J Virol"},{"key":"BF7700535_CR23","doi-asserted-by":"publisher","first-page":"5773","DOI":"10.1002\/j.1460-2075.1995.tb00266.x","volume":"14","author":"F Radecke","year":"1995","unstructured":"Radecke F, Spielhofer P, Schneider H et al. Rescue of measles viruses from cloned DNA EMBO J 1995 14: 5773\u20135784","journal-title":"EMBO J"},{"key":"BF7700535_CR24","doi-asserted-by":"publisher","first-page":"2087","DOI":"10.1128\/JVI.75.5.2087-2096.2001","volume":"75","author":"AL Hammond","year":"2001","unstructured":"Hammond AL, Plemper RK, Zhang J et al. Single-chain antibody displayed on a recombinant measles virus confers entry through the tumor-associated carcinoembryonic antigen J Virol 2001 75: 2087\u20132096","journal-title":"J Virol"},{"key":"BF7700535_CR25","unstructured":"Peng K, Donovan K, Schneider U et al. Oncolytic measles viruses displaying a single chain antibody against CD38, a myeloma cell marker submitted for publication"},{"key":"BF7700535_CR26","doi-asserted-by":"publisher","first-page":"9928","DOI":"10.1128\/JVI.74.21.9928-9936.2000","volume":"74","author":"U Schneider","year":"2000","unstructured":"Schneider U, Bullough F, Vongpunsawad S et al. Recombinant measles viruses efficiently entering cells through targeted receptors J Virol 2000 74: 9928\u20139936","journal-title":"J Virol"},{"key":"BF7700535_CR27","first-page":"1221","volume-title":"Fields' Virology","author":"JK Rose","year":"2001","unstructured":"Rose JK, Whitt MA . Rhabdoviridae: the viruses and their replication In: Knipe DM, Howley PM, eds Fields' Virology 4th edition Philadelphia: Lippincott, Williams and Wilkins 2001 Vol. 1: 1221\u20131244"},{"key":"BF7700535_CR28","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1128\/jvi.61.3.653-660.1987","volume":"61","author":"LS Belkowski","year":"1987","unstructured":"Belkowski LS, Sen GC . Inhibition of vesicular stomatitis viral mRNA synthesis by interferons J Virol 1987 61: 653\u2013660","journal-title":"J Virol"},{"key":"BF7700535_CR29","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1038\/77558","volume":"6","author":"DF Stojdl","year":"2000","unstructured":"Stojdl DF, Lichty B, Knowles S et al. Exploiting tumor-specific defects in the interferon pathway with a previously unknown oncolytic virus Nat Med 2000 6: 821\u2013825","journal-title":"Nat Med"},{"key":"BF7700535_CR30","doi-asserted-by":"publisher","first-page":"3474","DOI":"10.1128\/JVI.75.7.3474-3479.2001","volume":"75","author":"S Balachandran","year":"2001","unstructured":"Balachandran S, Porosnicu M, Barber GN . Oncolytic activity of vesicular stomatitis virus is effective against tumors exhibiting aberrant p53, Ras, or myc function and involves the induction of apoptosis J Virol 2001 75: 3474\u20133479","journal-title":"J Virol"},{"key":"BF7700535_CR31","doi-asserted-by":"publisher","first-page":"9580","DOI":"10.1128\/JVI.74.20.9580-9585.2000","volume":"74","author":"DF Stojdl","year":"2000","unstructured":"Stojdl DF, Abraham N, Knowles S et al. The murine double-stranded RNA-dependent protein kinase PKR is required for resistance to vesicular stomatitis virus J Virol 2000 74: 9580\u20139585","journal-title":"J Virol"},{"key":"BF7700535_CR32","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1006\/mthe.2000.0116","volume":"2","author":"NJ DePolo","year":"2000","unstructured":"DePolo NJ, Reed JD, Sheridan PL et al. VSV-G pseudotyped lentiviral vector particles produced in human cells are inactivated by human serum Mol Ther 2000 2: 218\u2013222","journal-title":"Mol Ther"},{"key":"BF7700535_CR33","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1128\/JVI.76.2.895-904.2002","volume":"76","author":"M Fernandez","year":"2002","unstructured":"Fernandez M, Porosnicu M, Markovic D et al. Genetically engineered vesicular stomatitis virus in gene therapy: application for treatment of malignant disease J Virol 2002 76: 895\u2013904","journal-title":"J Virol"},{"key":"BF7700535_CR34","first-page":"1597","volume-title":"Fields' Virology","author":"KL Tyler","year":"1996","unstructured":"Tyler KL, Fields BN . Mammalian reoviruses In: Fields BN, Knipe DM, Howley PM, eds Fields' Virology Philadelphia: Lippincott-Raven 1996 1597\u20131623"},{"key":"BF7700535_CR35","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1016\/0300-9084(94)90083-3","volume":"76","author":"LJ Mundschau","year":"1994","unstructured":"Mundschau LJ, Faller DV . Endogenous inhibitors of the dsRNA-dependent eIF-2 alpha protein kinase PKR in normal and ras-transformed cells Biochimie 1994 76: 792\u2013800","journal-title":"Biochimie"},{"key":"BF7700535_CR36","doi-asserted-by":"publisher","first-page":"3351","DOI":"10.1093\/emboj\/17.12.3351","volume":"17","author":"JE Strong","year":"1998","unstructured":"Strong JE, Coffey MC, Tang D et al. The molecular basis of viral oncolysis: usurpation of the Ras signaling pathway by reovirus EMBO J 1998 17: 3351\u20133362","journal-title":"EMBO J"},{"key":"BF7700535_CR37","doi-asserted-by":"publisher","first-page":"1332","DOI":"10.1126\/science.282.5392.1332","volume":"282","author":"MC Coffey","year":"1998","unstructured":"Coffey MC, Strong JE, Forsyth PA et al. Reovirus therapy of tumors with activated Ras pathway Science 1998 282: 1332\u20131334","journal-title":"Science"},{"key":"BF7700535_CR38","first-page":"1696","volume":"62","author":"K Hirasawa","year":"2002","unstructured":"Hirasawa K, Nishikawa SG, Norman KL et al. Oncolytic reovirus against ovarian and colon cancer Cancer Res 2002 62: 1696\u20131701","journal-title":"Cancer Res"},{"key":"BF7700535_CR39","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1089\/10430340252837233","volume":"13","author":"KL Norman","year":"2002","unstructured":"Norman KL, Coffey MC, Hirasawa K et al. Reovirus oncolysis of human breast cancer Hum Gene Ther 2002 13: 641\u2013652","journal-title":"Hum Gene Ther"},{"key":"BF7700535_CR40","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1093\/jnci\/93.12.903","volume":"93","author":"ME Wilcox","year":"2001","unstructured":"Wilcox ME, Yang W, Senger D et al. Reovirus as an oncolytic agent against experimental human malignant gliomas J Natl Cancer Inst 2001 93: 903\u2013912","journal-title":"J Natl Cancer Inst"},{"key":"BF7700535_CR41","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/S0065-3527(08)60356-5","volume":"53","author":"MR Roner","year":"1999","unstructured":"Roner MR . Rescue systems for dsRNA viruses of higher organisms Adv Virus Res 1999 53: 355\u2013367","journal-title":"Adv Virus Res"},{"key":"BF7700535_CR42","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1097\/00000441-190412740-00001","volume":"127","author":"G Dock","year":"1904","unstructured":"Dock G . Influence of complicating diseases upon leukaemia Am J Med Sci 1904 127: 563\u2013592","journal-title":"Am J Med Sci"},{"key":"BF7700535_CR43","first-page":"8188","volume":"61","author":"M Bergmann","year":"2001","unstructured":"Bergmann M, Romirer I, Sachet M et al. A genetically engineered influenza A virus with ras-dependent oncolytic properties Cancer Res 2001 61: 8188\u20138193","journal-title":"Cancer Res"},{"key":"BF7700535_CR44","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1006\/viro.2001.1008","volume":"287","author":"G Neumann","year":"2001","unstructured":"Neumann G, Kawaoka Y . Reverse genetics of influenza virus Virology 2001 287: 243\u2013250","journal-title":"Virology"},{"key":"BF7700535_CR45","doi-asserted-by":"crossref","first-page":"2425","DOI":"10.1128\/JVI.73.3.2425-2433.1999","volume":"73","author":"E Hatada","year":"1999","unstructured":"Hatada E, Saito S, Fukuda R . Mutant influenza viruses with a defective NS1 protein cannot block the activation of PKR in infected cells J Virol 1999 73: 2425\u20132433","journal-title":"J Virol"},{"key":"BF7700535_CR46","first-page":"685","volume-title":"Fields' Virology","author":"VR Racaniello","year":"2001","unstructured":"Racaniello VR . Picornaviridae: the viruses and their replication In: Knipe DM, Howley PM, eds Fields' Virology 4th edition Philadelphia: Lippincott, Williams and Wilkins 2001 Vol. 1: 685\u2013722"},{"key":"BF7700535_CR47","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/S0065-3527(08)60349-8","volume":"53","author":"DJ Evans","year":"1999","unstructured":"Evans DJ . Reverse genetics of picornaviruses Adv Virus Res 1999 53: 209\u2013228","journal-title":"Adv Virus Res"},{"key":"BF7700535_CR48","doi-asserted-by":"publisher","first-page":"6803","DOI":"10.1073\/pnas.97.12.6803","volume":"97","author":"M Gromeier","year":"2000","unstructured":"Gromeier M, Lachmann S, Rosenfeld MR et al. Intergeneric poliovirus recombinants for the treatment of malignant glioma Proc Natl Acad Sci USA 2000 97: 6803\u20136808","journal-title":"Proc Natl Acad Sci USA"}],"container-title":["Cancer Gene Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/7700535.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/7700535","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/7700535.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,22]],"date-time":"2022-03-22T13:13:40Z","timestamp":1647954820000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/7700535"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,11,22]]},"references-count":48,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2002,12,1]]}},"alternative-id":["BF7700535"],"URL":"https:\/\/doi.org\/10.1038\/sj.cgt.7700535","relation":{},"ISSN":["0929-1903","1476-5500"],"issn-type":[{"value":"0929-1903","type":"print"},{"value":"1476-5500","type":"electronic"}],"subject":[],"published":{"date-parts":[[2002,11,22]]},"assertion":[{"value":"12 September 2002","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 November 2002","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}